InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: DorseyE post# 940

Sunday, 07/23/2017 6:38:10 PM

Sunday, July 23, 2017 6:38:10 PM

Post# of 3872
08/15/2017
RHB-104 MAP US
Crohn’s disease
Phase 3 DSMB safety analysis released December 13, 2016 - trial to continue as planned. Interim efficacy analysis due early August 2017 - assume latest possible date is August 15.

09/30/2017
BEKINDA
IBS-D
Phase 2 top-line data due September 2017. Noted July 17, 2017 that last patient has been enrolled.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News